Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
Sell
38
CFLT Quote, Financials, Valuation and Earnings
Last price:
$28.81
Seasonality move
:
-3.23%
Day range:
$29.38 - $30.28
52-week range:
$17.79 - $35.07
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.32x
P/B ratio:
10.47x
Volume:
3.2M
Avg. volume:
3.7M
1-year change:
34.07%
Market cap:
$9.8B
Revenue:
$777M
EPS (TTM):
-$1.11
Analysts' Opinion
-
Consensus RatingConfluent has received a consensus rating of Buy. The company's average rating is a Buy based on 18 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $32.72, Confluent has an estimated upside of 9.71% from its current price of $29.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $25.00 representing 16.19% downside risk from its current price of $29.83.
Fair Value
-
According to the consensus of 26 analysts, Confluent has 9.71% upside to fair value with a price target of $32.72 per share.
CFLT vs. S&P 500
-
Over the past 5 trading days, Confluent has overperformed the S&P 500 by 1.63% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Confluent does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Confluent has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Confluent reported revenues of $250.2M.
Earnings Growth
-
Confluent has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Confluent reported earnings per share of -$0.23.
Enterprise value:
9B
EV / Invested capital:
--
Price / LTM sales:
10.32x
EV / EBIT:
--
EV / Revenue:
9.85x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-703.64x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$668.6M
Return On Assets:
-14.16%
Net Income Margin (TTM):
-38.35%
Return On Equity:
-41.28%
Return On Invested Capital:
-18.1%
Operating Margin:
-37.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $537.2M | $732.4M | $915.6M | $200.2M | $250.2M | |
| Gross Profit | $342.6M | $505.9M | $668.6M | $143.6M | $186.5M | |
| Operating Income | -$461.4M | -$474.2M | -$398M | -$108.1M | -$93.7M | |
| EBITDA | -$455M | -$461.8M | -$378.3M | -$104.5M | -$88M | |
| Diluted EPS | -$1.67 | -$1.54 | -$1.11 | -$0.30 | -$0.23 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $1.2B | $2.2B | $2.2B | $2.3B | |
| Total Assets | -- | $1.3B | $2.3B | $2.4B | $2.6B | |
| Current Liabilities | -- | $272.8M | $378.6M | $435.5M | $535M | |
| Total Liabilities | -- | $338.7M | $1.5B | $1.6B | $1.7B | |
| Total Equity | -- | $971.1M | $783.9M | $789.1M | $934.3M | |
| Total Debt | -- | -- | $1.1B | $1.1B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$154.1M | -$143M | $10.5M | -$9.1M | $15.6M | |
| Cash From Investing | -$1B | -$142.5M | -$77.1M | -$11.5M | -$21.9M | |
| Cash From Financing | $1.1B | $99.6M | $71.3M | $26.2M | $17.2M | |
| Free Cash Flow | -$167.6M | -$162M | -$12.8M | -$13.1M | $9.3M | |
CFLT
Sector
Market Cap
$9.8B
$128.7M
Price % of 52-Week High
85.06%
69.94%
Dividend Yield
0%
0%
Shareholder Yield
--
0.91%
1-Year Price Total Return
34.07%
-2.33%
Beta (5-Year)
--
0.919
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$29.06
200-day SMA
Buy
Level
$26.21
Bollinger Bands (100)
Buy
Level
20.23 - 29.39
Chaikin Money Flow
Buy
Level
137M
20-day SMA
Sell
Level
$30.18
Relative Strength Index (RSI14)
Buy
Level
51.87
ADX Line
Sell
Level
33.54
Williams %R
Neutral
Level
-46.7626
50-day SMA
Buy
Level
$28.86
MACD (12, 26)
Sell
Level
-0.13
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
99M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2956)
Sell
CA Score
(Annual)
Level (-1.9578)
Buy
Beneish M-Score
(Annual)
Level (-2.6657)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.2104)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.
Stock Forecast FAQ
In the current month, CFLT has received 18 Buy ratings 8 Hold ratings, and 0 Sell ratings. The CFLT average analyst price target in the past 3 months is $32.72.
-
Where Will Confluent Stock Be In 1 Year?
According to analysts, the consensus estimate is that Confluent share price will rise to $32.72 per share over the next 12 months.
-
What Do Analysts Say About Confluent?
Analysts are divided on their view about Confluent share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Confluent is a Sell and believe this share price will drop from its current level to $25.00.
-
What Is Confluent's Price Target?
The price target for Confluent over the next 1-year time period is forecast to be $32.72 according to 26 Wall Street analysts, 18 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is CFLT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Confluent is a Buy. 18 of 26 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CFLT?
You can purchase shares of Confluent via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Confluent shares.
-
What Is The Confluent Share Price Today?
Confluent was last trading at $28.81 per share. This represents the most recent stock quote for Confluent. Yesterday, Confluent closed at $29.83 per share.
-
How To Buy Confluent Stock Online?
In order to purchase Confluent stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
